FluBlok, a next generation influenza vaccine manufactured in insect cells.
about
Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activityOptimal Use of Vaccines for Control of Influenza A Virus in SwineLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsVaccines: the Fourth CenturyLow temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formationCurrent and emerging cell culture manufacturing technologies for influenza vaccines.Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.Continuous cell lines as a production system for influenza vaccines.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.Vaccine development for protecting swine against influenza virus.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesVaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity.Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.Effective chikungunya virus-like particle vaccine produced in insect cells.Hyper-enhanced production of foreign recombinant protein by fusion with the partial polyhedrin of nucleopolyhedrovirusTowards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron.Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and productionMolluscan cells in culture: primary cell cultures and cell lines.Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.Swine influenza vaccines: current status and future perspectives.Insect cell technology is a versatile and robust vaccine manufacturing platform.The future of cell culture-based influenza vaccine production.Vaccine process technology.Developments of subunit and VLP vaccines against influenza A virus.Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults.Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.Whole-Genome Sequence of the Spodoptera frugiperda Sf9 Insect Cell LineDissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines.Metabolic profiling of insect cell lines: Unveiling cell line determinants behind system's productivity.Flipase-mediated cassette exchange in Sf9 insect cells for stable gene expression.Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals.Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris.Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates.Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines.Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection.
P2860
Q24306734-DE0B7B1D-3312-4D6C-BA41-BFE1041067D2Q26783503-70391BE2-6517-4EAA-81C7-FD459505E9B6Q27013018-9A15AFF0-2BFA-45EE-8E39-2E29EB0513BFQ27490454-3194EFD2-DEC8-43F3-8F21-CBDE069B1E2FQ28744320-A33EC7BB-8991-4CEA-8EEC-26C0277C3B1BQ30373128-40A5CD6A-C02F-4959-8167-CA4F08B5A17AQ30374733-C9DCE20C-B1BE-4D69-B390-619E235E1C1DQ30382947-14AB8300-CED3-4ACD-88F9-D1F0985D3359Q30407424-EEF31E9B-E6BA-4C01-9BA0-EC734536BAD8Q30419591-E10365D3-6DDF-4CE8-821A-302FDE3DA748Q30424943-0CB06FDF-CFE5-42A3-9044-96E8F48593D3Q30427591-61BEF249-48EB-471B-9225-301003B63710Q30429880-71738EEF-0B26-47FB-96D3-F9D91C964A90Q33743890-178D2A6E-1F87-4D27-8917-CB50BCEC9D2AQ33962565-A93CBA74-D5C2-40E5-A079-05A4737CF6EBQ34630576-2EEFD35E-C047-4EC7-8C91-760B84E44143Q34674206-948D83F5-A1CA-4A69-AE08-15E1EE28CF2FQ34773596-76F0D7FA-4D63-4AC4-8896-63BA7C86C114Q35772241-EEA1FDF6-3853-4D82-819F-3CD0B272B5F5Q36496580-B8D055AF-3D92-49F5-AB17-ACB2BD9297C1Q37134971-B136F0B2-9280-4066-AABB-B5982D8502ECQ37277282-294D9FFB-B5B1-427E-BAB8-D8276B4BA0E3Q37375954-0FACF921-20E5-45E2-A628-04A470653AFCQ37749889-FD63C601-368B-4477-B864-EB2BE8A3004BQ37909427-52B94C7E-3C3A-40DD-9258-99F3400FDEA0Q37919896-71D28CF6-6FC1-46BE-840F-7FD451D58951Q37992586-E4EF5773-74E3-43C5-83DE-95F49B69A787Q38017605-C9CBEA1F-C861-42D4-815C-BB0823903E13Q38127585-081EEE0C-C284-407E-9B93-6312AD92410AQ38554795-5CEC2339-64BF-4F47-B16E-3FB0BDDDAE68Q38694239-91AC6D16-AA0F-4951-941C-F0468EBA99CCQ38878792-6EBD8AB1-E917-4BCD-864C-329B73A38BE3Q39011341-A275013B-5A8C-45DE-AB1F-0DEC12B108F2Q39060418-D386C2E0-FDBE-4BD1-B7FE-D8BC35ECB2A1Q39352224-637418A5-305C-4A55-B88D-1236684F24D6Q39568410-B36F9AAC-756D-4D3A-8359-5CC902CBEEDAQ40730375-DB1D7FDC-7047-4349-9896-9D4B3C4CD5B5Q40801596-852030E8-7216-4CDB-9AE0-A2DA211BC335Q41917947-CE35677C-4F6A-4EA9-B6DD-4289ACA09BEFQ45325594-22AD5192-1303-4030-91F5-AAC29CFBC964
P2860
FluBlok, a next generation influenza vaccine manufactured in insect cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@en
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@nl
type
label
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@en
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@nl
prefLabel
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@en
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@nl
P1433
P1476
FluBlok, a next generation influenza vaccine manufactured in insect cells.
@en
P2093
Jason R Hollister
Manon M J Cox
P304
P356
10.1016/J.BIOLOGICALS.2009.02.014
P577
2009-03-17T00:00:00Z